Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of marginal quality donors on the outcome of liver transplantation.
Briceno J, Lopez-Cillero P, Rufian S, Diaz-Iglesias C, Solorzano G, Padillo J, De la Mata M, Pera C. Briceno J, et al. Among authors: padillo j. Transplant Proc. 1997 Feb-Mar;29(1-2):477-80. doi: 10.1016/s0041-1345(96)00213-8. Transplant Proc. 1997. PMID: 9123091 No abstract available.
Influence of marginal donors on liver preservation injury.
Briceño J, Marchal T, Padillo J, Solórzano G, Pera C. Briceño J, et al. Among authors: padillo j. Transplantation. 2002 Aug 27;74(4):522-6. doi: 10.1097/00007890-200208270-00015. Transplantation. 2002. PMID: 12352912
Adjuvant chemotherapy for prevention of recurrence of invasive hepatocellular carcinoma after orthotopic liver transplantation.
Bernal E, Montero JL, Delgado M, Fraga E, Costán G, Barrera P, López-Vallejos P, Solórzano G, Rufián S, Briceño J, Padillo J, López-Cillero P, Marchal T, Muntané J, de la Mata M. Bernal E, et al. Among authors: padillo j. Transplant Proc. 2006 Oct;38(8):2495-8. doi: 10.1016/j.transproceed.2006.08.053. Transplant Proc. 2006. PMID: 17097979
Impact of Early Initiated Everolimus on the Recurrence of Hepatocellular Carcinoma After Liver Transplantation.
Rodríguez-Perálvarez M, Guerrero M, Barrera L, Ferrín G, Álamo JM, Ayllón MD, Artacho GS, Montero JL, Briceño J, Bernal C, Padillo J, Marín-Gómez LM, Pascasio JM, Poyato A, Gómez-Bravo MA, De la Mata M. Rodríguez-Perálvarez M, et al. Among authors: padillo j. Transplantation. 2018 Dec;102(12):2056-2064. doi: 10.1097/TP.0000000000002270. Transplantation. 2018. PMID: 29757893
[Indications and results of liver transplantation in cholestatic diseases].
de la Mata M, Montero JL, Fraga E, Delgado M, Costán G, Padillo J, Díaz C, Rufián S, López-Cillero P, Solórzano G, Pera C, Miño G. de la Mata M, et al. Among authors: padillo j. Gastroenterol Hepatol. 2000 Feb;23 Suppl 1:39-42. Gastroenterol Hepatol. 2000. PMID: 11968341 Review. Spanish. No abstract available.
Cytoprotective properties of rifampicin are related to the regulation of detoxification system and bile acid transporter expression during hepatocellular injury induced by hydrophobic bile acids.
González R, Cruz A, Ferrín G, López-Cillero P, Briceño J, Gómez MA, Rufián S, Padillo J, De la Mata M, Marin JJ, Muntané J. González R, et al. Among authors: padillo j. J Hepatobiliary Pancreat Sci. 2011 Sep;18(5):740-50. doi: 10.1007/s00534-011-0396-3. J Hepatobiliary Pancreat Sci. 2011. PMID: 21526375
BNP as marker of heart dysfunction in patients with liver cirrhosis.
Padillo J, Rioja P, Muñoz-Villanueva MC, Vallejo JA, Ciria R, Muntane J, Sitges-Serra A, Solórzano G, De la Mata M. Padillo J, et al. Eur J Gastroenterol Hepatol. 2010 Nov;22(11):1331-6. doi: 10.1097/MEG.0b013e32833e6b2a. Eur J Gastroenterol Hepatol. 2010. PMID: 20729741
50 results